RenovoRx, Inc.
General ticker "RNXT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $47.0M (TTM average)
RenovoRx, Inc. follows the US Stock Market performance with the rate: 15.4%.
Estimated limits based on current volatility of 3.7%: low 0.87$, high 0.94$
Factors to consider:
- Total employees count: 8 (-11.1%) as of 2023
- Top business risk factors: Limited operating history, Significant losses, Third-party risks, Labor/talent shortage/retention, Market disruptions
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.77$, 2.16$]
- 2025-12-31 to 2026-12-31 estimated range: [0.73$, 2.09$]
Financial Metrics affecting the RNXT estimates:
- Positive: with PPE of -3.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -30.71 <= 0.33
- Positive: 41.86 < Shareholder equity ratio, % of 55.16 <= 63.39
- Positive: Investing cash flow per share per price, % of -0.04 > -0.66
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Net income
Short-term RNXT quotes
Long-term RNXT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.04MM |
| Operating Expenses | $9.95MM | $11.40MM | $11.01MM |
| Operating Income | $-9.95MM | $-11.40MM | $-10.97MM |
| Non-Operating Income | $0.06MM | $1.16MM | $2.16MM |
| Interest Expense | $0.00MM | $0.11MM | $0.00MM |
| R&D Expense | $4.30MM | $5.67MM | $6.03MM |
| Income(Loss) | $-9.89MM | $-10.23MM | $-8.81MM |
| Profit(Loss)* | $-9.89MM | $-10.23MM | $-8.81MM |
| Stockholders Equity | $6.16MM | $-3.00MM | $4.48MM |
| Assets | $7.26MM | $1.47MM | $8.12MM |
| Operating Cash Flow | $-8.81MM | $-10.26MM | $-9.12MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.01MM |
| Investing Cash Flow | $-2.03MM | $2.03MM | $-0.01MM |
| Financing Cash Flow | $0.04MM | $5.01MM | $15.12MM |
| Earnings Per Share** | $-0.55 | $-0.50 | $-0.37 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.